Published • loading... • Updated
Bial Showcases Parkinson’s Research at MDS 2026 – Novumpr
Summary by Novumpr | En Nog Een WordPress Site
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Bial Showcases Parkinson’s Research at MDS 2026 – Novumpr
New data provide insights into the experiences and perceptions of people living with Parkinson’s and treatment outcomes Three posters and one oral presentation focus on the discontinued investigational compound BIA 28-6156 [INTENDED FOR MEDICAL AND TRADE MEDIA ONLY] PORTO, Portugal–(BUSINESS WIRE)– Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, is presenting 16 […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
